{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:18:15Z","timestamp":1772039895315,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T00:00:00Z","timestamp":1268611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10067-010-1422-6","type":"journal-article","created":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T21:47:03Z","timestamp":1268516823000},"page":"1195-1197","source":"Crossref","is-referenced-by-count":47,"title":["Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis"],"prefix":"10.1007","volume":"29","author":[{"given":"Daichi","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Kawanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Takiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonoko","family":"Shimoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumie","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soshi","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,15]]},"reference":[{"key":"1422_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","volume":"358","author":"JD Gillmore","year":"2001","unstructured":"Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24\u201329","journal-title":"Lancet"},{"key":"1422_CR2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrgastro.2009.147","volume":"6","author":"PT Sattianayagam","year":"2009","unstructured":"Sattianayagam PT, Hawkins PN, Gillmore JD (2009) Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 6:608\u2013617","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1422_CR3","first-page":"408","volume":"26","author":"R Koivuniemi","year":"2008","unstructured":"Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M (2008) Amyloidosis as a cause of death in patients with rheumatoid arthritis. Clin Exp Rheumatol 26:408\u2013413","journal-title":"Clin Exp Rheumatol"},{"key":"1422_CR4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s10067-009-1185-0","volume":"28","author":"H Sato","year":"2009","unstructured":"Sato H, Sakai T, Sugaya T, Otaki Y, Aoki K, Ishii K et al (2009) Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 28:1113\u20131116","journal-title":"Clin Rheumatol"},{"key":"1422_CR5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/ard.2008.099267","volume":"68","author":"S Nishida","year":"2009","unstructured":"Nishida S, Hagihara K, Shima Y, Kawai M, Kuwahara Y, Arimitsu J et al (2009) Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment. Ann Rheum Dis 68:1235\u20131236","journal-title":"Ann Rheum Dis"},{"key":"1422_CR6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14712598.8.5.669","volume":"8","author":"Y Ohsugi","year":"2008","unstructured":"Ohsugi Y, Kishimoto T (2008) The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis. Exp Opin Biol Ther 8:669\u2013681","journal-title":"Exp Opin Biol Ther"},{"key":"1422_CR7","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361\u20132371","journal-title":"N Engl J Med"},{"key":"1422_CR8","first-page":"518","volume":"25","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S (2007) Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol 25:518\u2013522","journal-title":"Clin Exp Rheumatol"},{"key":"1422_CR9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10067-008-0875-3","volume":"27","author":"ME Perry","year":"2008","unstructured":"Perry ME, Stirling A, Hunter JA (2008) Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis. Clin Rheumatol 27:923\u2013925","journal-title":"Clin Rheumatol"},{"key":"1422_CR10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","volume":"54","author":"RN Maini","year":"2006","unstructured":"Maini RN, Taylor PC, Szechinski J, Pavelka K, Broll J, Balint G et al (2006) Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 54:2817\u20132829","journal-title":"Arthritis Rheum"},{"key":"1422_CR11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2443.2005.00900.x","volume":"10","author":"K Hagihara","year":"2005","unstructured":"Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T et al (2005) Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells 10:1051\u20131063","journal-title":"Genes Cells"},{"key":"1422_CR12","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","volume":"48","author":"JE Gottenberg","year":"2003","unstructured":"Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B et al (2003) Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arthritis Rheum 48:2019\u20132024","journal-title":"Arthritis Rheum"},{"key":"1422_CR13","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/art.22118","volume":"54","author":"Y Okuda","year":"2006","unstructured":"Okuda Y, Takasugi K (2006) Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum 54:2997\u20133000","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1422-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1422-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:40Z","timestamp":1559105500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1422-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,15]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1422-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,15]]}}}